CDK4, RRM2 and CCNB2 were related to p53 signalling pathway (hsa04115), which might activate the p53 signalling pathway via CDK4, RRM2 and CCNB2, might also have regulatory effects in glioma cells. The gene discussed is CDK4; the disease is central nervous system cancer.